ARTICLE | Company News
Ares-Serono and Amrad deal
January 27, 2000 8:00 AM UTC
Ares-Serono (SWX:AREB) and Amrad (ASX:AML) will use AML's recombinant leukemia inhibitory factor (LIF) to treat female infertility. AML is developing LIF for neuromuscular diseases. AML received an up...